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Papillary fibroelastoma of aortic
valve: Early diagnosis and surgical
management
To the Editor:
We read with great interest the article by
Vagefi and associates1 regarding their ex-
perience with papillary fibroelastoma of the
aortic valve. We had a similar experience
with 2 patients having very small papillary
fibroelastomas who were referred to us and
had their tumors excised urgently.
A 68-year-old woman presented to her
general practitioner with a 3-month history
of symptoms including one transient isch-
emic attack (TIA).2 The patient subsequently
underwent echocardiography, which demon-
strated a mobile mass attached by a thin stalk
to the aortic valve. A 15-mm long and 2 mm
in diameter tumor attached to the noncoro-
nary cusp of the aortic valve was resected
with standard cardiopulmonary bypass.
A 67-year-old man was referred with a
recent history of multiple TIAs. Various
investigations including carotid Doppler
and transthoracic echocardiogram were in-
conclusive. However transesophageal echo-
cardiography (TEE) revealed a 5  1-mm
pedunculated tumor attached to the aortic
valve. At the time of surgery, a small tumor
with a thin stalk was found attached to the
undersurface of the left coronary cusp
(Figure 1). Both patients had an uncom-
plicated recovery and were discharged
home on day 5.
Our patients were very similar to the
case reported by Vagefi and colleagues in
that both had an early diagnosis of the
tumor made by echocardiography on the
basis of neurologic symptoms. Both of our
patients had their tumors shaved off the
structurally normal aortic valve on an ur-
gent basis. At the conclusion of the proce-
dure, intraoperative TEE demonstrated a
competent aortic valve with no evidence of
residual tumor or aortic insufficiency.
It seems that an early diagnosis of these
tumors is being made with very small masses
detected with echocardiography. We empha-
size the importance of prompt excision of
these tumors owing to the risk of preopera-
tive thromboembolic phenomena.3
Pankaj Saxena, MCh, DNB
Igor E. Konstantinov, MD, PhD
Andrew Lee, MBBS
Mark A. J. Newman, FRACS
Department of Cardiothoracic Surgery
Sir Charles Gairdner Hospital
Nedlands, WA, Australia
Figure 1. Papillary fibroelastoma excised from aortic valve of patient 2.
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Suture annuloplasty for mitral
valve repair
To the Editor:
We read with great interest your article
published in the January issue of the Jour-
nal of Thoracic Cardiovascular Surgery.1
At our department the modified Paneth an-
nuloplasty suture was introduced in 1992
and has been used in 866 cases until the
end of 2005.
The cause of the mitral incompetence,
the early mortality, and the reoperation rate
in the different groups are summarized in
Table 1. Approximately half of the annu-
loplasties were performed to correct annu-
lar dilatation secondary to severe aortic
valve disease or ischemic heart disease.
Our policy for secondary annular dilatation
is that if the mitral regurgitation is grade 2
or more on admission, a suture annulo-
plasty is performed, even if the valve is
structurally normal. In patients in whom
the mitral valve was structurally abnormal
(primary mitral valve disease), a wide
range of procedures were performed, in-
cluding valvotomy, quadrangular resection,
sliding leaflet plasty, patch repair of the
anterior leaflet, annular decalcification, and
repair of the anterior leaflet. The suture
annuloplasty was also used in a few cases
of dilated cardiomyopathy to restore the
mitral valve competence.
Since 2002, 56 patients have required
reoperation for severe recurrent mitral re-
gurgitation. After complex valve repair
there were 37 reoperations (9.2%): 25 in
the degenerative group, 12 in the rheumatic
group, and none after endocarditis. In the
secondary annular dilatation group, 14 pa-
tients required valve replacement because
of recurrent ischemic mitral incompetence
(5.6%). The worst results were obtained in
patients with dilated cardiomyopathy.
On the basis of the results of our pioneer
series, the suture material was changed from
3-0 Prolene to 3-0 polytetrafluoroethylene
(Gore-Tex, WL Gore and Associates, Flag-
staff, Ariz ).2 However, over the years we
had 4 cases of early failure (within 1 week
after repair) caused by broken polytetra-
fluoroethylene (Gore-Tex) sutures. In all
cases the intraoperative transesophageal
echocardiography confirmed good valve
competence. At the time of reoperation, the
suture was in the annulus but broke just at
the knot in all cases. Recently, we also had
a case in which the suture cut through the
annulus creating a string in the mitral an-
nulus and causing severe hemolysis 5 years
after the original operation.
Overall, our long-term results with su-
ture annuloplasty combined with complex
mitral valve repair are inferior to the results
with ring implantation. However, using the
technique for the repair of secondary annu-
lar dilatation is safe and gives reproducible
long-term results. Moreover, in ischemic
mitral regurgitation the annuloplasty su-
ture might help to restore and preserve
the normal annular and leaflet dynamic
motion.3,4
Zsolt L. Nagy, MD, PhD
Arpad Peterffy, MD, PhD
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Reply to the Editor:
We appreciate the comments by Nagy and
Peterffy.1 Their respectable experience
with the modified Paneth annuloplasty su-
ture for mitral valve repair in more than
800 cases extends well over a decade; nev-
ertheless, their results support our conclu-
sion that suture annuloplasty may not be a
durable treatment option.2
In their hands, early postoperative re-
sults were satisfactory as the repair resulted
in competent valve with preserved annular
and mural leaflet mobility. Contrary to our
experience, they have not seen any intra-
operative left circumflex artery injury.
Over the years of follow-up, 56 (6.47%)
patients returned for reoperation. They re-
port that suture knot insufficiency was the
cause of recurrent mitral regurgitation. The
majority of reoperated valves, however,
were insufficient mainly due to recurrent
ring dilatation, with the worst results ob-
tained in the ischemic and dilated cardio-
myopathy groups.
Again, the durability of the suture an-
nuloplasty is questioned. Contrarily, the
evidence that a prosthetic ring annuloplasty
stabilizes the repair in a more durable fash-
ion is accumulating.3 In a well-constructed
study, Cohn and coworkers were among
TABLE 1. Cause of mitral incompetence, mortality, and reoperation rate in
patients who underwent suture mitral annuloplasty between 1992 and 2005
No. of cases Mortality Reoperation
Mitral valvular pathology 403 3 (0.7%) 37 (9.2%)
Degenerative 302 2 (0.7%) 25 (8.3%)
Rheumatic 80 1 (1.2%) 12 (15.2%)
Endocarditis 21 0 (0%) 0 (0%)
Annular dilatation 463 27 (5.8%) 19 (4.4%)
Ischemic 268 18 (6.7%) 14 (5.6%)
Aortic valve disease 160 5 (3.1%) 0 (0%)
Dilated cardiomyopathy 35 4 (11.5%) 5 (16%)
Letters to the Editor
850 The Journal of Thoracic and Cardiovascular Surgery ● March 2007
